Zoledronate synergises with imatinib mesylate to inhibit Ph primary leukaemic cell growth.
Segawa H, Kimura S, Kuroda J, Sato K, Yokota A, Kawata E, Kamitsuji Y, Ashihara E, Yuasa T, Fujiyama Y, Ottmann OG, Maekawa T.
Segawa H, et al. Among authors: kuroda j.
Br J Haematol. 2005 Aug;130(4):558-60. doi: 10.1111/j.1365-2141.2005.05648.x.
Br J Haematol. 2005.
PMID: 16098070
Free article.